On July 24, 2023, Robert B. Brown informed Fresh Tracks Therapeutics, Inc. (the “Company”) of his resignation from the Company’s Board of Directors (the “Board”), effective immediately.
Key facts
Extracted from this filing and checked against the source text.
Executive changeSEC 8-K Item 5.02confidence 0.95
Robert B. Brown resigned as Director at Fresh Tracks Therapeutics, Inc..
Action
resigned
Role
Director
Exact text from the filing
On July 24, 2023, Robert B. Brown informed Fresh Tracks Therapeutics, Inc. (the “Company”) of his resignation from the Company’s Board of Directors (the “Board”), effective immediately.
Fresh Tracks Therapeutics, Inc.: Board adopted Amended and Restated Bylaws to reduce the minimum number of directors from four to three, and subsequently reduced the board size accordingly (effective 2023-07-24).
Change
bylaw amendment
Effective
2023-07-24
Exact text from the filing
On July 24, 2023, the Board adopted Amended and Restated Bylaws to decrease the minimum number of directors from four members to three members.
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.